statistiche ricercatore

Continente	#
NA - Nord America	1.191
EU - Europa	461
AS - Asia	138
SA - Sud America	8
OC - Oceania	6
AF - Africa	3
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.808

Nazione	#
US - Stati Uniti d'America	1.188
GB - Regno Unito	141
IT - Italia	71
DE - Germania	67
SE - Svezia	67
CN - Cina	37
HK - Hong Kong	35
FI - Finlandia	22
UA - Ucraina	22
TR - Turchia	21
BE - Belgio	13
IN - India	13
FR - Francia	12
BG - Bulgaria	10
NL - Olanda	10
TW - Taiwan	7
RU - Federazione Russa	6
AU - Australia	5
HU - Ungheria	5
IE - Irlanda	4
JP - Giappone	4
KR - Corea	4
PK - Pakistan	4
VN - Vietnam	4
BR - Brasile	3
MY - Malesia	3
PT - Portogallo	3
BZ - Belize	2
CH - Svizzera	2
CO - Colombia	2
IR - Iran	2
RO - Romania	2
TN - Tunisia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
AT - Austria	1
BH - Bahrain	1
CA - Canada	1
CL - Cile	1
EC - Ecuador	1
ID - Indonesia	1
IL - Israele	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PE - Perù	1
SI - Slovenia	1
TH - Thailandia	1
ZA - Sudafrica	1
Totale	1.808

Nome	#
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening	245
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women	225
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat	211
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors	196
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region.	195
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer.	194
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor	165
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study	157
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores	137
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness	117
Totale	1.842

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	102	0	0	0	0	0	0	0	0	0	0	45	57
2019/2020	420	24	20	23	31	37	90	68	42	39	17	18	11
2020/2021	328	35	12	33	35	33	16	19	35	22	47	19	22
2021/2022	273	16	14	33	16	5	22	14	22	35	22	48	26
2022/2023	307	35	40	20	38	31	33	8	36	36	1	17	12
2023/2024	168	7	12	16	14	44	13	21	30	7	4	0	0
Totale													1.842